Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable?
- PMID: 39556657
- DOI: 10.1161/CIRCULATIONAHA.124.071851
Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable?
Keywords: Editorials; arrhythmias, cardiac; foramen ovale, patent.
Conflict of interest statement
Dr Tobis was a member of the steering committee of PREMIUM (Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine), is sponsored by Abbott, and is a consultant to ReCross. Dr Carroll is a member of the steering committee of RESPECT (Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment), is sponsored by Abbott, and is a consultant to ReCross.
Comment on
-
Flecainide to Prevent Atrial Arrhythmia After Patent Foramen Ovale Closure: AFLOAT Study, A Randomized Clinical Trial.Circulation. 2024 Nov 19;150(21):1659-1668. doi: 10.1161/CIRCULATIONAHA.124.071186. Epub 2024 Sep 2. Circulation. 2024. PMID: 39222035 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources